Donepezil

Aricept, Donepezil

Cholinesterase Inhibitor

NADAC/unit $0.0443

No Shortage Tier 1: 237.4% 20 Manufacturers 41 ANDAs

Donepezil slows cognitive decline in Alzheimer's disease by preserving acetylcholine levels.

vs. brand Aricept: Generic saves up to 100% per unit

Covered Lives

Market Intelligence

2024-01-03 Class II Recall: CARDINAL HEALTHCARE

Generic Manufacturers

ALEMBIC PHARMACEUTICALS LTDAUROBINDO PHARMA LTDCADILA PHARMACEUTICALS LTDCHARTWELL RX SCIENCES LLCCIPLA LTDDEXCEL PHARMA TECHNOLOGIES LTDDR REDDYS LABORATORIES LTDEISAI INCHETERO LABS LTD UNIT VHISUN PHARMACEUTICAL HANGZHOU CO LTDJUBILANT GENERICS LTDMACLEODS PHARMACEUTICALS LTDNOVITIUM PHARMA LLCPRINSTON PHARMACEUTICAL INCRISING PHARMA HOLDING INCSCIEGEN PHARMACEUTICALS INCSTRIDES PHARMA GLOBAL PTE LTDTORRENT PHARMACEUTICALS LTDTWI PHARMACEUTICALS INCZYDUS LIFESCIENCES LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Donepezil drfinder.aiFind doctors who prescribe Donepezil inhomecare.aiLearn about dementia care rxnews.aiLatest news about Donepezil

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.